CompoAtlas

Complexe de macérats miellés de bourgeons - Maux d'hiver

Food supplement declared in France, declaration No 2022-9-1356

Complexe de macérats miellés de bourgeons - Maux d'hiver (Cybèle Nature) is a food supplement declared in France. Status: earlier declaration, replaced by the 2025 declaration. None of the rules we check flags an issue with its declared composition.

Brand
Cybèle Nature
Food business operator placing the product on the market
E.I Cybèle nature
Status
Earlier declaration, replaced by the 2025 declaration : Complexe de macérats miellés de bourgeons - Maux d'hiver
Form
Compte-gouttes
Daily dose
0,1g
Directions for use
1 à 20 gouttes par jour, diluées dans un verre d’eau, en dehors des repas pendant 21 jours.
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Voies respiratoires, Immunité

Declaration 167225, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Alnus glutinosa (L.) Gaertn.BourgeonAutre macérât0.1 g
Pinus sylvestris L.BourgeonAutre macérât0.1 g
Populus nigra L.BourgeonAutre macérât0.1 g
Ribes nigrum L.BourgeonAutre macérât0.1 g
Rosa canina L.Jeune pousseAutre macérât0.1 g
Rosmarinus officinalis L.Jeune pousseAutre macérât0.1 g

Other active ingredients

NamePer day
mielnot declared

Other ingredients

Alcool

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

1 à 5 gouttes par jour, diluées dans un verre d’eau, en dehors des repas pendant 21 jours.Dose journalière recommandée : 0,1g.Respecter les doses conseillées. Complément alimentaire.Ne peut se substituer à un régime alimentaire équilibré. Tenir hors de la portée des enfants. Conserver dans un endroit frais et à l’abri de la lumière.Déconseillé chez la femme enceinte et en cas d’allaitement

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Rosmarinus officinalis L.
    Read the warning, when it applies and the studies cited

    ROSEMARY – ROSMARINUS OFFICINALIS Oral

    Route of administration: Oral (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 May 2026

    ROSEMARY - ROSMARINUS OFFICINALIS Topical

    Route of administration: Topical (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have large open wounds, skin lesions, feverish conditions, acute inflammation, severe circulatory disorders or hypertension (ESCOP 2003).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Barnes et al. 2007; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 May 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Cybèle Nature

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line